The biological and physiological impact of the performance of wound dressings

被引:35
作者
Cullen, Breda [1 ]
Gefen, Amit [2 ]
机构
[1] RedC Consultancy, Bradford, W Yorkshire, England
[2] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, Tel Aviv, Israel
关键词
chronic wounds; clinical outcomes; dressing design and evaluation; exudate; wound healing; EXTRACELLULAR BACTERIAL PROTEASES; SKIN; FLUID; PH; INFLAMMATION; REPAIR; FIBROBLASTS; INHIBITOR; MECHANISM; INFECTION;
D O I
10.1111/iwj.13960
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Chronic wounds affect millions globally and are a huge financial burden. Whilst there are many wound dressings commercially available to manage these wounds, the complexity of the repair process makes it difficult to select the right dressing for the right wound at the right time. Thus, in this narrative review, we have examined reasons why wounds fail to heal, summarised the pathophysiology of the chronic wound environment and provided an evidence-based, clinically-relevant compilation of the published literature relevant to dressing design and evaluation. This has highlighted the need for a deeper understanding of wound exudates, how exudates change throughout the healing process, and how they are impacted by different dressing materials. Studies assessing biochemical and biophysical changes in exudates throughout the healing process are extremely valuable in this regard, enhancing both our understanding of the wound healing process and the ability to assess dressing performance. In addition, this knowledge allows us to replicate various wound conditions in the laboratory, and develop clinically-relevant models for testing current and new dressings, therefore providing a more comprehensive understanding of how and when they should be used. This approach makes the use of dressings more effective, thereby improving outcomes, and reducing the economic burden of chronic wounds.
引用
收藏
页码:1292 / 1303
页数:12
相关论文
共 92 条
[1]  
[Anonymous], 2011, REV DIGEST, DOI DOI 10.1089/9781934854280.273
[2]   Wound healing: potential therapeutic options [J].
Bosanquet, D. C. ;
Harding, K. G. .
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (02) :149-158
[3]   REACTIVE OXYGEN SPECIES (ROS) - A FAMILY OF FATE DECIDING MOLECULES PIVOTAL IN CONSTRUCTIVE INFLAMMATION AND WOUND HEALING [J].
Bryan, Nicholas ;
Ahswin, Helen ;
Smart, Neil ;
Bayon, Yves ;
Wohlert, Stephen ;
Hunt, John A. .
EUROPEAN CELLS & MATERIALS, 2012, 24 :249-265
[4]  
Bryant R., 2007, ACUTE CHRONIC WOUNDS, V3rd
[5]   TISSUE INHIBITOR OF METALLOPROTEINASES-1 IS DECREASES AND ACTIVATED GELATINASES ARE INCREASED IN CHRONIC WOUNDS [J].
BULLEN, EC ;
LONGAKER, MT ;
UPDIKE, DL ;
BENTON, R ;
LADIN, D ;
HOU, ZZ ;
HOWARD, EW .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (02) :236-240
[6]   Tumor necrosis factor-alfa in nonhealing venous leg ulcers [J].
Charles, Carlos A. ;
Romanelli, Paolo ;
Martinez, Zuleika Bonilla ;
Ma, Fangchao ;
Roberts, Brenda ;
Kirsner, Robert S. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (06) :951-955
[7]   Development of a Model to Predict Healing of Chronic Wounds Within 12 Weeks [J].
Cho, Sang Kyu ;
Mattke, Soeren ;
Gordon, Hanna ;
Sheridan, Mary ;
Ennis, William .
ADVANCES IN WOUND CARE, 2020, 9 (09) :516-524
[8]   Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers [J].
Cullen, B ;
Smith, R ;
McCulloch, E ;
Silcock, D ;
Morrison, L .
WOUND REPAIR AND REGENERATION, 2002, 10 (01) :16-25
[9]  
Cullen B., 2005, WHS, V13, pA4
[10]  
Cullen B., 2016, WOUNDS INT, V7, P10